U.S. Dried Blood Spot Collection Cards Market (By Application: New Born Screening (NBS), Forensics; By Card Type: Whatman 903, FTA; By End-use) - Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2024-2033

U.S. Dried Blood Spot Collection Cards Market Size and Growth

The U.S. dried blood spot collection cards market size was estimated at around USD 115.33 million in 2023 and it is projected to hit around USD 169.9 million by 2033, growing at a CAGR of 3.95% from 2024 to 2033.

Key Pointers

• By Application, the newborn screening held the largest revenue share of 24% in 2023 and is expected to grow at a significant CAGR of 3.33% from 2024 to 2033.
• By Application, the forensics segment is expected to expand at the highest CAGR of 4.43% from 2024 to 2033.
• By Card Type, the Whatman 903 segment contributed the largest market share in 2023 and is expected to grow with the fastest CAGR between 2024 to 2033.
• By End-use, the hospitals & clinics segment generated the maximum market share in 2023.

U.S. Dried Blood Spot Collection Cards Market Overview

In the United States, the market for dried blood spot collection cards is experiencing significant growth and evolution. These cards, used for collecting blood samples via a simple and minimally invasive process, are finding increasing applications across various sectors such as healthcare, pharmaceuticals, and research.

U.S. Dried Blood Spot Collection Cards Market Growth Factors

In the United States, the growth of the market for dried blood spot collection cards is driven by an increasing demand for point-of-care testing solutions is fueling the adoption of dried blood spot collection cards, which offer a convenient and minimally invasive method for collecting blood samples. Technological advancements in analytical techniques have also contributed to market growth by improving the accuracy and reliability of tests conducted using dried blood spot samples. Furthermore, the expansion of newborn screening programs across the country has boosted the usage of these cards in early disease detection. The cost-effectiveness and convenience of dried blood spot collection cards compared to traditional venous blood collection methods are driving their widespread adoption in clinical diagnostics and research applications. Lastly, the growing focus on personalized medicine has spurred the demand for dried blood spot collection cards, as they enable the collection of biological samples for genetic testing and biomarker analysis.

U.S. Dried Blood Spot Collection Cards Market Trends:

• Rising Demand for Point-of-Care Testing: There is an increasing preference for point-of-care testing methods, driving the demand for dried blood spot collection cards due to their convenience and minimally invasive nature.
• Expansion of Newborn Screening Programs: The expansion of newborn screening programs across the U.S. is fueling the demand for dried blood spot collection cards, as they are extensively used in early disease detection.
• Growing Focus on Personalized Medicine: The increasing focus on personalized medicine is driving the demand for dried blood spot collection cards, as they enable the collection of biological samples for genetic testing and biomarker analysis.
• Increased Research and Development Activities: There is a surge in research and development activities aimed at enhancing the performance and versatility of dried blood spot collection cards, leading to the introduction of innovative solutions in the market.
• Integration of Digital Technologies: Digital technologies such as mobile health applications and cloud-based platforms are being integrated with dried blood spot collection cards, enabling remote sample collection and data management, thus driving market growth.

U.S. Dried Blood Spot Collection Cards Market Restraints:

• Regulatory Challenges: Stringent regulatory requirements and standards for blood sample collection and testing may pose challenges for the adoption of dried blood spot collection cards, especially in clinical settings.
• Limited Sample Volume: Dried blood spot collection cards may have limitations in sample volume compared to traditional venous blood collection methods, which could affect the sensitivity and accuracy of certain tests, particularly those requiring larger sample volumes.
• Sample Stability Concerns: There may be concerns regarding the stability of dried blood spot samples during storage and transportation, which could impact the reliability of test results, especially for analytes prone to degradation.
• Variability in Sample Quality: Variability in blood sample quality collected using dried blood spot collection cards, due to factors such as improper handling or storage conditions, may affect the reproducibility and accuracy of test results.
• Limited Multiplexing Capability: While efforts are being made to develop multiplex testing capabilities for dried blood spot collection cards, their current capacity for simultaneous analysis of multiple biomarkers may be limited compared to other sample collection methods, which could restrict their utility in certain applications.
• Perception and Acceptance Issues: Despite their advantages, dried blood spot collection cards may face resistance or skepticism from healthcare professionals and patients accustomed to traditional blood collection methods, impacting their adoption rate.

Application Insights

Newborn screening held the largest revenue share of 24% in 2023 and is expected to grow at a significant CAGR of 3.33% during the forecast period. This growth is attributed to the rising number of newborn screenings. According to the Network for Public Health Law, in 2023, each state health department in the U.S. had a newborn screening program. These programs enabled early detection of severe conditions in approximately 13,000 babies every year, proving to be a crucial public health initiative. Moreover, the state health department of U.S. manages a newborn screening program to assess newborns for specific genetic, endocrine, and metabolic disorders. These tests help safeguard the long-term health and survival of infants.

The forensics segment is estimated to witness the fastest growth of CAGR of 4.43% during the forecast period. This is attributed to the increasing applications of DBS collection cards in forensics and enhanced storage ability of DBS collection cards holding genetic information. For instance, according to the National Library of Medicine (NLM), in 2018, the Guthrie cards holding DBS samples could be economically transported via airmail across different continents. These cards could maintain the quality needed for gDNA extraction, enabling Sanger sequencing procedures to be carried out efficiently in overseas laboratories.

Card Type Insights

The Whatman 903 segment dominated the market with the largest share in 2023 and is expected to grow with the fastest CAGR throughout the forecast period due to its cost-effectiveness, ease of use, compatibility with various techniques such as ELISA, PCR, and spectrometry, and high binding capacity allowing efficient sample preparation. For instance, as of 2023, Tisch Scientific offered a Whatman 903 Protein Saver cards pack of 100 for around USD 200 on its online platform. The affordability of Whatman 903 cards is expected to impact its adoption rate positively. These cards also help preserve samples by preventing degradation and protecting them from environmental factors such as temperature and humidity, ensuring they remain stable during transportation and storage.

The FTA segment is expected to witness lucrative growth during the forecast period, due to its numerous benefits in various applications, such as stability, compatibility with multiple techniques involving DNA sequencing, low cost, RNA preservation, environmental friendliness, and sample elution capabilities. These features make FTA a valuable forensics, biology, and medical research tool.

End-use Insights

The hospitals & clinics segment dominated the market and accounted for the largest revenue share in 2023, with a lucrative growth rate over the forecast period. DBS collection cards have gained significant importance in hospitals and clinics due to their convenience, cost-effectiveness, and versatility. These cards are primarily used for collecting, storing, and transporting small blood samples for various diagnostic tests and research purposes.

The others segment is estimated to witness the fastest growth during the forecast period. This is attributed to some benefits, such as affordability, ease of use, and ability to do sampling at home, which limits hospital-based sampling and increases patient compliance. In May 2022, according to the National Library of Medicine, blood sampling at home is expected to reduce hospital visits, reduce patient burden, increase compliance, and increase the quality of life of patients. This is one of the potential factors supporting the segment growth in the upcoming years. Furthermore, at-home DBS blood sampling is also expected to reduce healthcare costs.

U.S. Dried Blood Spot Collection Cards Market Key Companies:

• Whatman plc (Cytiva)
• GE Healthcare
• MilliporeSigma
• QIAGEN LLC
• PerkinElmer
• Roche
• Shimadzu Corporation
• Ahlstrom-Munksjö
• Eastern Business Forms, Inc.
• CENTOGENE N.V.

Recent Developments

• In February 2024, Cytiva and LevitasBio joined forces to offer an advanced single-cell methodology catering to genomics experts in academia and industry alike.
• In January 2024, Cytiva emphasized its capacity and provision of tailored solutions for diagnostic services as needed.

U.S. Dried Blood Spot Collection Cards Market Segmentation:

By Application

• Newborn Screening (NBS)
• Infectious Diseases Testing
• Therapeutic Drug Monitoring
• Forensics
• CRO/Research
• Other Applications

By Card Type

• Whatman 903
• Ahlstrom 226
• FTA
• Others

By End-use

• Hospitals & Clinics
• Diagnostics Centers
• Others

By Country

• West
• Midwest
• Northeast
• Southwest
• Southeast